Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 0 | 1,998 | 597 | 0 |
| Cost of Goods | N/A | -1 | 667 | 191 | N/A |
| Gross Profit | N/A | 1 | 1,331 | 406 | N/A |
| Operating Expenses | 35,086 | 38,873 | 28,301 | 47,418 | 44,981 |
| Operating Income | -35,086 | -38,873 | -26,303 | -46,821 | -44,981 |
| Interest Expense | 538 | 575 | 572 | 568 | 613 |
| Other Income | 1,529 | 5,913 | 6,044 | -51 | -5,310 |
| Pre-tax Income | -34,095 | -33,535 | -20,831 | -47,440 | -50,904 |
| Income Tax | 1,087 | 85 | -541 | 60 | -335 |
| Net Income Continuous | -35,182 | -33,620 | -20,290 | -47,500 | -50,569 |
| Net Income | $-35,182 | $-33,620 | $-20,290 | $-47,500 | $-50,569 |
| EPS Basic Total Ops | -3.10 | -3.40 | -2.00 | -4.80 | -5.10 |
| EPS Basic Continuous Ops | -3.06 | -3.34 | -2.04 | -4.79 | -5.12 |
| EPS Diluted Total Ops | -3.10 | -3.40 | -2.00 | -4.80 | -5.10 |
| EPS Diluted Continuous Ops | -3.06 | -3.34 | -2.04 | -4.79 | -5.12 |
| EBITDA(a) | $-34,694 | $-38,517 | $-25,530 | $-46,380 | $-46,190 |